Appeals court sides with Medicare in fight over drug price power
Court upholds drug price negotiation program, rejecting BMS and Janssen challenge Philadelphia, PA – A federal appeals court has upheld the Biden administration’s authority to negotiate Medicare drug prices, rejecting claims by pharmaceutical giants Bristol Myers Squibb and Janssen that…
